1. 1884 The incidence and clinical significance of ESR1 mutations in patients with heavily pretreated metastatic breast cancer. (September 2015) Authors: Niu, J.; Andres, G.; Kramer, K.; Kundranda, M.; Weiss, G.; Klimant, E.; Parikh, A.; Tan, B.; Staren, E.; Markman, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Consolidation therapy revisited: intravenous chemotherapy. (1st October 2003) Authors: Markman, M. Journal: International journal of gynecological cancer Issue: Volume 13(2003)Supplement 2 Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Epithelial Ovarian Cancer: Focus on Targeted Therapy. (15th June 2011) Authors: Markman, M.; Sehouli, Jalid; Levenback, Charles F.; Chi, Dennis S. Journal: Journal of oncology Issue: Volume 2010(2010) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology Group. Issue 2 (1st February 2004) Authors: Alberts, D. S.; Jiang, C.; Liu, P. Y.; Wilczynski, S.; Markman, M.; Rothenberg, M. L. Journal: International journal of gynecological cancer Issue: Volume 14:Issue 2(2004) Page Start: 224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Maintenance chemotherapy in advanced ovarian cancer: the US experience. (1st February 2008) Authors: Markman, M. Journal: International journal of gynecological cancer Issue: Volume 18(2008)Supplement 1 Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211). Issue 4 (1st July 2007) Authors: Alberts, D. S.; Liu, P. Y.; Wilczynski, S. P.; Jang, A.; Moon, J.; Ward, J. H.; Beck, J. T.; Clouser, M.; Markman, M. Journal: International journal of gynecological cancer Issue: Volume 17:Issue 4(2007) Page Start: 784 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Principles and practice of intraperitoneal chemotherapy for ovarian cancer. Issue 1 (1st January 2007) Authors: Fujiwara, K.; Armstrong, D.; Morgan, M.; Markman, M. Journal: International journal of gynecological cancer Issue: Volume 17:Issue 1(2007) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Progress in ovarian cancer research: Proceedings of the 5th Biennial Ovarian Cancer Research Symposium. Issue 2 (1st March 2006) Authors: Disis, M. L.; Rivkin, S. E.; Baron, A.; Markman, M.; Connolly, D.; Ueland, F.; Kohn, E.; Trimble, E.; Berek, J. S. Journal: International journal of gynecological cancer Issue: Volume 16:Issue 2(2006) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Strategies to examine new compounds for intraperitoneal use in ovarian cancer. (1st February 2008) Authors: Markman, M. Journal: International journal of gynecological cancer Issue: Volume 18(2008)Supplement 1 Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Surgery alone or surgery with a combination radiation or chemoradiation for management of patients with bulky-stage IB2 cervical carcinoma. Issue 3 (1st April 2006) Authors: Micha, J. P.; Goldstein, B. H.; Rettenmaier, M. A.; Brown, J. V.; John, C. R.; Markman, M. Journal: International journal of gynecological cancer Issue: Volume 16:Issue 3(2006) Page Start: 1147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗